Zobrazeno 1 - 6
of 6
pro vyhledávání: '"van Laar SA"'
Autor:
Abedian Kalkhoran H; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands. h.abedian_kalkhoran@lumc.nl.; Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands. h.abedian_kalkhoran@lumc.nl., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Storm BN; Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands., van Laar SA; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands., Portielje JE; Department of Internal Medicine - Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands., Codrington H; Department of Pulmonary Diseases - Pulmonic Oncology, Haga Teaching Hospital, The Hague, The Netherlands., Luijten D; Department of Pulmonary Diseases - Pulmonic Oncology, Haga Teaching Hospital, The Hague, The Netherlands., Brocken P; Department of Pulmonary Diseases - Pulmonic Oncology, Haga Teaching Hospital, The Hague, The Netherlands., Smit EF; Department of Pulmonary Disease, Leiden University Medical Centre, Leiden, The Netherlands., Visser LE; Department of Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands.; Department of Hospital Pharmacy, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Publikováno v:
BMC cancer [BMC Cancer] 2023 Mar 14; Vol. 23 (1), pp. 247. Date of Electronic Publication: 2023 Mar 14.
Autor:
van Laar SA; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Gombert-Handoko KB; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Zwaveling J; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Nov 03; Vol. 14 (21). Date of Electronic Publication: 2022 Nov 03.
Autor:
van Laar SA; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Gombert-Handoko KB; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Wassenaar S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, 2333ZA, Leiden, The Netherlands. j.zwaveling@lumc.nl.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Nov; Vol. 30 (11), pp. 9181-9189. Date of Electronic Publication: 2022 Aug 31.
Autor:
van Laar SA; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Gombert-Handoko KB; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Groenwold RHH; Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Visser LE; Department of Hospital Pharmacy, Haga Teaching Hospital, The Hague, Netherlands.; Department of Epidemiology, Erasmus MC, Rotterdam, Netherlands.; Department of Hospital Pharmacy, Erasmus MC, Rotterdam, Netherlands., Houtsma D; Department of Internal Medicine, Haga Teaching Hospital, The Hague, Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, Netherlands.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Mar 23; Vol. 13, pp. 803935. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Autor:
van Laar SA; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., de Boer MGJ; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Gombert-Handoko KB; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Nov; Vol. 87 (11), pp. 4450-4454. Date of Electronic Publication: 2021 May 04.
Autor:
van Laar SA; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Gombert-Handoko KB; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2020 Sep; Vol. 108 (3), pp. 644-652. Date of Electronic Publication: 2020 Jul 18.